Subscribe to Newsletter
Discovery & Development Advanced Medicine, Drug Discovery, Formulation, Trends & Forecasts

Video Interview: Vered Caplan

Covering everything from manufacturing, regulatory relations, and future prospects for growth – join us as we gain detailed insights on the latest industry trends from Vered Caplan!

Vered Caplan is an active entrepreneur in the life science space. From founding and leading over 15 companies, to spearheading the development of Orgenesis as CEO, her experience extends across OTC products, pharmaceuticals, biologics, cell therapy and medical devices.

In the past Vered held the position of CEO at Kamedis, CEO of Gammacan International, and President for Catalent MSTC.Vered’s career began in Life Sciences after receiving a graduate degree from Tel-Aviv University and an undergraduate degree from Technion-Israel Institute of Technology.

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Jamie Irvine

Associate Editor, The Medicine Maker

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine